PAID CLINICAL TRIAL
- Lasting 2 years
- 13 clinic visits
YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:
- Are 12 years of age or older
- Diagnosis of Asthma
The Purpose of this study will research whether starting depemokimab earlier, while asthma is still considered not severe – along with usual asthma treatment – can reduce asthma attacks and help achieve better asthma control and healthier lung function, compared with placebo (an injection with noactive ingredients). The study will also look at lung function, asthma control, quality of life, and safety.
Lynn Institute is a leader in introducing new medications to the market through our clinical trials program. Visit our Participation Information page for Frequently Asked Questions, to see current clinical trials listed, and to find out where each trial is being conducted.
Find out More About Our Participation Program
Participation Information